# SARC046 (NCT07104331)

> SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT07104331
- Phase: PHASE2
- Status: RECRUITING
- Sponsor: Sarcoma Alliance for Research through Collaboration
- Conditions: Epithelioid Hemangioendothelioma (EHE)
- Interventions: nab-Sirolimus
- Enrollment: 41
- Primary outcome: Tumor response rate

## Indexed commentary on SARC046 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 2
- YouTube: 1

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=sarc046-nct07104331